创新药物医保准入中的阈值
汤金燕, 王瑞欣, 闫萱萱, 王一清, 应晓华
创新药物医保准入中的阈值
Cost-effectiveness threshold considerations in innovative drug access
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |